A shot in the arm
Researchers develop new, patient-friendly hydrogel platform for administering lifesaving biologics.
Researchers develop new, patient-friendly hydrogel platform for administering lifesaving biologics.
Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases.
Developed at SMART, the therapy stimulates the host immune system to more effectively clear bacterial infections and accelerate infected wound healing.
Senior Mercy Oladipo is building tools to address disparities in health care.
Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.
Aided by machine learning, scientists are working to develop a vaccine that would be effective against all SARS-CoV-2 strains.
MIT engineers find specialized nanoparticles can quickly and inexpensively isolate proteins from a bioreactor.
The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.
“I feel a great connection to my community, and I always want to find a way to give back,” says the Rhodes Scholar and Air Force ROTC wing commander.
The soft robotic models are patient-specific and could help clinicians zero in on the best implant for an individual.
The sensor sends out its location as it moves through the GI tract, revealing where slowdowns in digestion may occur.
The chatbot’s success on the medical licensing exam shows that the test — and medical education — are flawed, Celi says.
Immunology research, public health service, and student leadership are all part of senior Julian Zulueta’s journey toward becoming a physician-scientist.
MIT Open Learning team awarded NIH grant to provide training in biomedical product development, entrepreneurship, and innovation.